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Editor’s key points
† The contribution of
saphenous nerve
afferents to pain after
major ankle surgery
remains unclear.
† Pain scores at rest were
low with no differences
between the groups at
any time point.
† Pain on movement up to
48 h and at 6 months
was lower in the
popliteal-femoral group.
† Further studies are
required to confirm these
findings.
Background. The contribution of the saphenous nerve in pain after major ankle surgery is
unknown. The aim of this study was to evaluate its contribution in this context.
Methods. Fifty patients were included in this prospective, randomized, controlled study. In
all patients [Group P (popliteal) and Group F (popliteal+femoral)], a popliteal catheter was
placed before operation and ropivacaine 0.5% (30 ml) administered via this catheter; major
ankle surgery was then performed under spinal anaesthesia. In Group PF patients, an
additional femoral catheter was sited before operation and ropivacaine 0.5% (10 ml)
administered. Six hours after spinal anaesthesia (defined as T0), a continuous infusion of
ropivacaine 0.3% (14 ml h21) was started through the popliteal catheter until T24. Then,
the concentration was reduced to 0.2% until T48. Patients in Group PF received
continuous ropivacaine 0.2% (5 ml h21) through the femoral catheter from T0 to T48. I.V.
morphine patient-controlled analgesia was used as a rescue analgesia. Pain at rest, pain
with movement, adverse effects, and i.v. morphine consumption were assessed. Pain at
rest and on movement was evaluated 6 months after operation.
Results. Pain at rest was comparable in the two groups. In Group PF, patients had
significantly reduced pain during movement in the postoperative period (P¼0.01) and 6
months after operation (P¼0.03). Morphine consumption was significantly reduced in
Group PF at T0–T24 and T24–T48 (P¼0.01). Adverse effects were comparable in both groups.
Conclusions. The addition of continuous femoral catheter infusion of ropivacaine to a
continuous popliteal catheter infusion improved postoperative analgesia during
movement after major ankle surgery. This effect was still present 6 months after surgery.
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Ankle arthrodesis, subtalar joint fusion, and total ankle repla-
cement are known to be associated with severe and pro-
longed postoperative pain.1 Pain in the territories of the
tibial and peroneal nerves has been shown to be well con-
trolled by the use of a popliteal nerve catheter for continu-
ous2 or patient-controlled3 4 local anaesthetic application.
However, pain in the area of the saphenous nerve has
been reported.5 When blocked in the groin, at the level
where the femoral nerve is blocked, the saphenous nerve
can be blocked with a success rate of 95%.6
The aim of this prospective, randomized, controlled, and
open study was to investigate the analgesic effect of a con-
tinuous femoral catheter added to a continuous popliteal
catheter after major ankle surgery; we hypothesized that
the addition of a continuous femoral catheter would
enhance the quality of postoperative analgesia. The
primary endpoint was postoperative pain intensity in the
first 48 postoperative hours; secondary endpoints were post-
operative morphine consumption and pain at rest and during
movement 6 months after surgery.
Methods
After approval of the local ethical committee (Kantonale
Ethikkommission, Gesundheitsdirektion des Kantons Zu¨rich)
and written informed consent were obtained, 53 adult
patients of both sexes (classified as ASA physical status I–
III, aged 18–75 yr, body mass index of 20–40 kg m22)
undergoing elective major ankle surgery involving both the
lateral and medial parts of the ankle were included.
Written informed consent was obtained during the preopera-
tive consultation 1 week before hospital admission. Exclusion
criteria were myocardial infarction within the last 6 months,
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chronic pain, preoperative opioid therapy, known allergy to
one of the study drugs, inability to use or understand a
patient-controlled analgesia (PCA) device, infection at the
nerve block puncture site, known neuropathy, and chronic
liver and/or renal disease with laboratory values over twice
the upper limit of normal. Secondary exclusion criteria after
randomization were inappropriate catheter placement (no
sensory and motor block 20 min after block performance),
catheter dislocation, or accidental catheter removal before
end of study completion.
The evening before surgery, patients were instructed on
the use of the visual analogue scale (VAS: 0, no pain at all;
100, worst pain imaginable) and the morphine PCA device
for rescue analgesia. Group assignment was performed
according to a computerized randomization list: Group P
received a continuous popliteal catheter for postoperative
regional analgesia (without additional continuous femoral
catheter); Group PF had an additional continuous femoral
catheter (i.e. combined continuous popliteal and
femoral catheters). Both groups had an i.v. morphine PCA
for rescue analgesia (no basal rate, 2 mg morphine bolus,
10 min lock-out time).
On the day of surgery, all patients were orally premedi-
cated with midazolam (0.1 mg kg21 with a maximum dose
of 7.5 mg) 1 h before regional anaesthesia. After arrival in
the preoperative induction room, standard monitoring (elec-
trocardiography, blood oxygen saturation, non-invasive
arterial pressure measurement) and peripheral venous
access were attained. In all patients, a continuous popliteal
catheter was placed with patients in the prone position
according to a technique described by our group.3 4 The prox-
imal end of the metal inner of the 21 G, 100 mm short-bevel
needle (Polymedicw, Polyplex, Te me na, Carnie`res-sur-Seine,
France) was connected to a nerve stimulator (Stimuplex HNS
11w; B. Braun Melsungen AG, Melsungen, Germany), with the
initial setting: 1.4 mA current intensity, 0.1 ms impulse dur-
ation with 2 Hz impulse frequency. The final needle position
was considered successful when foot inversion3 4 was
obtained with a minimal current output of 0.3–0.4 mA and
with an impulse duration of 0.1 s. A 20 G perineural catheter
(Polymedicw, Polyplex, Te me na, Bondy, France) was placed
with the cannula over needle technique by threading the
perineural catheter 3 cm past the tip of the cannula. After
subcutaneous tunnelling for 4–5 cm, the popliteal catheter
was fixed with transparent adhesive tape and connected to
a 200 nm microfilter. Ropivacaine 0.5% (30 ml) (150 mg)
was injected incrementally through the catheter using
repeated aspiration tests.
In Group PF after performance of the popliteal catheter as
described above, the puncture site for femoral block was
located 5 cm below a line joining the anterior superior iliac
crest spine and the pubic tubercle and 1–2 cm lateral to the
femoral artery. The final needle position was considered to
be correct if a ‘dancing patella’ sign was elicited with
minimal current output of 0.3–0.4 mA, at 0.1 ms impulse dur-
ation and 2 Hz impulse frequency. Femoral catheter place-
ment was performed in a way similar to that described for
the popliteal catheter. Ropivacaine 0.5% (10 ml) (50 mg)
was administered incrementally through the catheter using
repeated aspiration tests. The popliteal and the femoral
nerve blocks were assessed by the attending anaesthetist 30
min after the administration of the local anaesthetics.
Block success for the popliteal block was evaluated using
the presence of pins-and-needles-type of paraesthesia at the
tip of the first, third, and fifth toes, the degree of sensory
block (cold test) was assessed over the distribution area of
the tibial, deep, and superficial peroneal nerve every 5 min,
for 20 min, and the degree of motor block was assessed
over the distribution area of the corresponding nerves (no
motor block, partial motor block, and complete motor
block) every 5 min, for 20 min. In Group PF, the sensory func-
tion (cold test) of the saphenous nerve at the level of the
medial malleolus was checked every 5 min for 20 min.
Motor weakness of the quadriceps was assessed every 5
min for 20 min. Block success was defined (i) as complete
sensory block over all corresponding dermatomes (popliteal
block) and over the territory of the saphenous nerve
(femoral block) and (ii) complete motor block of the corre-
sponding nerves for the popliteal block and at least a
partial motor loss of the quadriceps for the femoral block.
Spinal anaesthesia was performed in all patients because
of the use of a thigh tourniquet. Patients were positioned in
the lateral decubitus position, with the operated site upward
to avoid accidental removal of the perineural catheters
during this procedure. A 27 G spinal needle (Whitacre,
Becton Dickinson AG, Basel, Switzerland) was introduced at
the level L4/5 or L3/4 using a paramedian approach. After
free backflow of cerebrospinal fluid, 12.5–15 mg isobaric
bupivacaine 0.5% was slowly injected according to the
patient’s age, height, and body mass index.
Acetaminophen 1 g was administered i.v. and repeated
every 6 h until the end of the study. All surgeries were per-
formed by the same surgeon. When necessary for intra-
operative sedation, propofol was administered using a
target-controlled infusion system (Deltec Croseby 3500,
Laubscher, Basel, Switzerland and Diprifusor subsystem,
AstraZeneca Ltd, Macclesfield, Cheshire, UK). Sedation was
given according to the patient’s requests in cases of
anxiety, discomfort, or patient’s wishes to be slightly
sedated. Propofol i.v. infusion was started at 0.2 mg ml21 at
the estimated effect site and slowly titrated up to a
maximum of 0.8 mg ml21 until the patient was comfortable.
The maximum of 0.8 mg ml21 was set to avoid deep sedation
with respiratory depression and loss of airway control.
After the end of surgery, patients were transferred to the
post-anaesthesia care unit (PACU). When arriving in the
PACU, all patients received an i.v. morphine PCA device for
rescue analgesia (Pain Management Provider, Abbott AG,
Baar, Switzerland) with no basal infusion, a 2 mg bolus,
and lock-out time of 10 min. When the upper sensory level
of the spinal anaesthesia was below the 10th thoracic der-
matome, the criteria according to the modified Aldrete
score were fulfilled and the postoperative pain was controlled
(VAS ,30), patients were transferred to the ward.
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T0 of the study was defined as 6 h after the end of
intrathecal bupivacaine administration. At T0, a continu-
ous infusion of ropivacaine 0.3% was started at a rate of
14 ml h21 until T24. At T24, the infusion rate was
reduced to 0.2% until T48. In Group PF, the continuous
local anaesthetic infusion through the femoral catheter
was initiated at T0 with ropivacaine 0.2% at a rate of 5
ml h21 and continued until T48. At T48, all local anaes-
thetic infusions were stopped. If pain on the VAS at rest
was below 30 within the next 3 h, the catheters were
withdrawn. During the study period, additional bolus of
i.v. morphine (2 mg) were applied by a member of the
acute pain service if VAS was .30 despite appropriate
use of the PCA device.
According to surgical prescription, patients were allowed
to mobilize on the morning of the first postoperative day
with crutches without weight-bearing on the operated foot.
Therefore, any transient weakness of the quadriceps
muscle caused by the femoral nerve catheter did not lead
to delayed mobilization. Patients were allowed to partially
bear weight after the fifth postoperative day.
A study nurse unaware of the purpose of the study per-
formed data collection. During the night, patients were not
specifically awakened for data collection. Data assessment
consisted of:
(i) Postoperative pain at rest and during mobilization
was assessed by means of the VAS. Pain at rest
was assessed at arrival in the recovery room, at T0,
and then every 6 h until T48. Pain during mobilization
(rolling through a walking step over a flat floor
without any weight including dorsal extension and
plantar flexion) was evaluated at T24 and then
every 6 h until T48. Ankle pain was assessed in
detail to distinguish between pain over the medial
and over the lateral aspect of the ankle.
(ii) Postoperative i.v. morphine consumption was regis-
tered separately for the time periods T02T24 and
T24–T48. Total morphine requirements included mor-
phine application with the PCA device and sup-
plementary morphine bolus.
(iii) Nausea and vomiting (graded with a three-point
score: 0, no; 1, nausea; 2, vomiting) and pruritus
(graded with a three-point score: 0, no; 1, mild, no
treatment needed; 2, severe, therapy required)
were recorded whenever they occurred.
(iv) The level of sedation was assessed using the Ramsay
sedation score every 6 h until T48.
(v) Clinical signs of central nervous system or cardiac
local anaesthetic intoxication were noted whenever
they occurred.
(vi) The puncture points of perineural catheters were
observed for infectious complications twice daily.
Local inflammation was defined as redness, swelling,
or pain on pressure at the catheter insertion site.
Local infection was defined as the occurrence of
pus around the catheter insertion site.
(vii) To detect the development of new neurological defi-
cits, a clinical examination was performed by one of
the investigators (S.B.) with special consideration to
weakness, numbness, and paraesthesia in all patients
on the day before surgery, 24 h after perineural cath-
eters removal, and 6 months after surgery.
(viii) Patients were asked to rate their overall satisfaction
with postoperative pain management on a scale
ranging from 0 (not satisfied at all) to 10 (very satis-
fied) 24 h after T48.
(ix) A clinical follow-up was performed 6 months after
operation, during routine surgical consultation in the
outpatient clinic. Patients were asked to rate their
pain intensity using a VAS at rest and with movement
(while walking on the floor with maximal flexion and
extension). Additionally, regular pain medication was
assessed. A neurological examination was performed
separately by both the anaesthetist (S.B.) and the
responsible surgeon.
Statistical analysis
A previous pilot study in our department (unpublished data)
has shown a variation of pain severity with movement of
30% in this surgical context. A 25% pain reduction in Group
PF during the first 48 postoperative hours was considered
to be significant. On the basis of these data, a power analysis
indicated that a sample size of 25 patients per group was
sufficient to have an 80% power with a two-sided 95% sig-
nificance level. Anticipating a dropout rate of 3%, 53 patients
were included in the study.
Patient satisfaction scores were compared with the
Mann–Whitney test. VAS scores and rescue morphine con-
sumption were analysed using the Mann–Whitney test with
Bonferroni’s correction for multiple repeated measurements.
Adverse effects were compared using the x2 test. For all
determinations, P,0.05 was considered significant. For stat-
istical analysis, the software SPSS for windows, version 11.5
(SPSS Inc., Chicago, IL, USA), was used.
Results
Among 53 randomized patients, 25 in each group completed
the study (Table 1, Fig. 1). Mean pain at rest was similar
between the two groups at all time points. No patient in
either group had pain at arrival in the recovery room. Three
patients in Group P reported a VAS of 15–25 when discharged
to the ward compared with none in Group PF. Maximal pain
at rest occurred in both groups between T12 and T30. In
Group P, three patients reported no pain at any time, com-
pared with 12 patients in Group PF (P¼0.04).
Postoperative pain during mobilization (Fig. 2) was signifi-
cantly lower at T24, T30, T36, T42, and T48 in Group PF (P¼0.01).
All patients in Group P had pain during mobilization com-
pared with 12 in Group PF, who did not report pain during
mobilization at any time (P¼0.03).
In Group PF, morphine consumption was significantly lower
from T0 to T24 and from T24 to T48. Supplementary morphine
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bolus administration was necessary in 52% of patients in
Group PF and in 96% in Group P (P¼0.03) (Table 2).
The incidence of postoperative nausea, vomiting, and
pruritus was similar in the two groups. No clinical signs of
local anaesthetic intoxication were reported. No sign or
symptom of perineural catheter infection was observed. At
T48, redness at the catheter insertion site was observed in
seven popliteal catheters in each group and eight femoral
catheters in Group PF. No sign or symptom of new neurologi-
cal complications was observed 24 h after catheter removal
in any patient. Patient satisfaction at 24 h after catheter
removal was similar in both groups (scores 8.9 and 9.1 in
Groups P and PF, respectively).
No patient was lost to follow-up 6 months after surgery,
and at this time, all patients were able to walk without a
walker. Pain at rest was comparable in both groups, but
pain with movement (walking on the floor) was significantly
lower in Group PF (Fig. 3) (P¼0.03). In Group P, two patients
reported no pain while walking, compared with nine patients
in Group PF (P¼0.03). These 11 patients had no or low
(maximal VAS of 15) pain scores during mobilization in the
postoperative period. Six months after surgery no patient
was using opioids, but five patients in Group P were taking
anti-inflammatory agents at regular intervals, compared
with one patient in Group PF. No neurological complication
was observed in any patient.
Discussion
In this study, we found that the addition of a femoral cath-
eter to a popliteal catheter provided significant better pain
control during early mobilization. This positive effect on
pain with movement was also observed 6 months after
operation.
During our investigation, pain at rest was treated effec-
tively in both groups. Since pain intensity at rest was
already low in Group P, a much larger study size would
have been necessary to demonstrate a possible significant
reduction of pain at rest in Group PF.7 The maximal pain at
rest in our study occurred between T12 and T30. This time-
frame is comparable with the results of di Benedetto and col-
leagues,5 who performed a study with a popliteal catheter
Assessed for eligibility:
Randomized: 53
Primary exclusion: 40 
- Exclusion criteria: 32 
- Refusal to participate: 8 
Allocated to Group P: 26
(only popliteal catheter) 
Allocated to Group PF: 27
(popliteal and femoral)
Analysed: 25 Analysed: 25
Secondary exclusion: 
- Catheter failure: 1 
- Accidental catheter removal: 1 
Secondary exclusion: 
- Intraoperative change of
  surgical procedure: 1
Fig 1 Patient flow diagram. Study design according to the CONSORT statement.
Table 1 Patient characteristics and surgical data. Values are
expressed as mean (range), mean (SD) or as absolute numbers (n)
Group P
(n525)
Group PF
(n525)
Gender (female/male) 9/16 10/15
Age (yr) 54 (22–78) 58 (41–80)
Body mass index (kg m22) 28 (4) 27 (4)
Preoperative pain at rest 32 (9) 37 (11)
Preoperative pain during
walking
49 (31) 48 (25)
Operated side (right/left) 12/13 14/11
Duration of tourniquet (min) 99 (14) 104 (18)
Duration of surgery (min) 114 (37) 117 (26)
Type of surgery
Ankle arthrodesis (n) 11 9
Ankle prosthesis (n) 14 16
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and single-shot femoral nerve block after foot surgery.
However, in our study, patients had considerably less pain.
This difference might be explained by the vanishing effect
of the femoral nerve single-shot block as a short-acting
local anaesthetic without additives was given.8
Pain during mobilization was significantly better con-
trolled in Group PF at any time. It is known that pain with
movement (in contrast to pain at rest) cannot be well
managed with opioids.9 The saphenous nerve is the terminal
sensitive cutaneous branch of the femoral nerve. It has been
shown that all major nerves of the lower leg, including the
saphenous nerve, contribute to the innervation of both the
capsule of the ankle and the talo-calcaneonavicular joint.10
During movement, the capsule gets stressed and these
movements may explain the higher pain intensities in
Group P. The results of this work support this anatomical
arrangement and therefore highlight the role of the saphe-
nous nerve in pain during ankle mobilization.
The significantly lower postoperative morphine consump-
tion in Group PF and the fact that 12 patients in this group did
not need any supplementary morphine confirms the better
analgesia provided by two continuous perineural catheters
in this surgical context. The results in Group P are in accord-
ance with the findings of Chelly and colleagues11 who found
a significant reduction in morphine comparing continuous
popliteal catheters with morphine PCA.
The significant lower pain during mobilization at 6 months
observed in Group PF can be related to the better pain control
in the early postoperative period. There is more and more
evidence that the intensity of postoperative pain is linked
to the development of the chronification of postoperative
pain. The results of this study are in accordance with this
concept. Kalso and colleagues12 were among the first to
demonstrate a link between the intensity of postoperative
pain and chronic pain after thoracotomy. These results
were also supported by Senturk and colleagues13 and
Pluijms and colleagues.14 Katz and colleagues15 found, in a
paper looking specifically at risk factors, that early post-
operative pain was the only factor that significantly predicted
long-term pain. Investigations after iliac crest bone graft-
ing,16 hernia surgery,17 hip arthoplasty,18 and Caesarean sec-
tions19 confirmed that postoperative pain was a risk factor.
The mechanisms responsible for the chronification of post-
operative pain are still not well defined.20 Further studies
are needed to elucidate this question.
Our observations can be criticized since we did not specify
the nerve distribution, the characteristics of pain observed 6
months after operation and its impact on the patient’s daily
quality of life, or the range of movement in the ankle. These
secondary outcome variables should be more closely investi-
gated in further prospective studies.
In the context of two combined continuous nerve
blocks, the issue of local anaesthetic toxicity must be con-
sidered. It was shown that the simultaneous continuous
application of ropivacaine at two different sites can be per-
formed without reaching toxic plasma concentration.16 21 In
this context, we performed a preliminary pilot study (unpub-
lished results), which demonstrated that total and free
(¼unbound) ropivacaine plasma concentration were well
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Fig 2 Postoperative pain during mobilization in patients of Group P
with a popliteal catheter (blue filled bars) and in patients of Group
PF with the popliteal and femoral catheters (green striped bars).
Data were assessed at T24 and then every 6 h until T48. Boxplots
represent median, 25th and 75th percentile and the whiskers rep-
resent the 10th and 90th percentile. *P¼0.01
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Fig 3 Pain with movement at 6 months after operation. Pain with
movement in patients of Group P and in patients of Group PF.
Data were assessed 6 months after operation while patients
were walking on the floor. Boxplots represent median, 25th and
75th percentile, and the whiskers represent the 10th and 90th
percentiles. *P¼0.03.
Table 2 Postoperative morphine consumption (mg). Results are
expressed as mean (SD). *P,0.05 between the groups
Time period Group P Group PF
0–24 h 25 (10) 6 (5)*
24–48 h 24 (11) 9 (5)*
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below the toxic threshold defined by Knudsen and
colleagues.22
It is possible that the higher plasma concentrations of
ropivacaine were responsible for the better analgesia.
However, Herroeder and colleagues23 infused lidocaine i.v.
(bolus 1.5 mg kg21 followed by a 4 h continuous infusion of
2 mg min21) or the same volume of placebo for colorectal
surgery and compared pain scores. Besides different interest-
ing positive effects of lidocaine, no influence on pain ratings
was found.
With regard to the site of saphenous nerve block, it could
be argued that a more specific continuous saphenous nerve
block in the distal part of the thigh would be more appropri-
ate than a continuous femoral nerve block. This would avoid
unnecessary proximal muscle weakness. However, the
patients in this study were allowed to be mobilized on the
morning of the first postoperative day with crutches
without weight-bearing of the operated foot. Therefore, the
transient weakness of the quadriceps muscle caused by the
femoral nerve catheter did not lead to a delayed mobiliz-
ation. Conversely, blockade of the saphenous nerve at the
level of the groin using a nerve stimulator has the advantage
of a higher success rate. Furthermore, the placement of a
perineural catheter at this level is easier.24
We recognize that in our study, a third group with a single-
shot saphenous block using ropivacaine 0.5% is lacking. This
would have perhaps given information dealing with the con-
troversy surrounding single-shot vs continuous infusion,
although it has been shown, in different regional anaesthesia
procedures, that a continuous administration of local anaes-
thetic offers better analgesia compared with single-shot
application.25
Pain was referred to as pain in the ankle, since it was not
possible for the patients to reliably distinguish the pain over
the medial aspect vs pain over the lateral aspect of the ankle,
especially since the whole area was covered with dressings
and a cast.
The design of this study may also be criticized since the
results can be expected and are not surprising. Ankle
surgery involving the medial aspect of the ankle will cause
pain in the area innervated by the saphenous nerve.
However, how important is the pain specifically related to
the saphenous nerve in this context is not known and has
never been investigated. This work emphasizes the role of
this nerve in the occurrence of pain with movement. For prac-
tical reasons, a real double-blinded design was not possible in
this investigation—the placement of the femoral catheter was
visible for both the patient and the study nurse. We cannot
exclude that this point may have influenced the results.
Reviews dealing with anaesthesia for foot surgery do not
mention the double-catheter technique.26 – 28 In clinical prac-
tice, the effectiveness of this ‘double catheter technique’
should be balanced against costs, workload, and a possible
increase in the risk of complications.
In conclusion, we found that analgesia after major ankle
surgery when performed by a combination of continuous
popliteal and femoral nerve block significantly reduced
early postoperative pain with movement and postoperative
morphine consumption. This positive effect was still present
6 months after operation.
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